Home

Scott L. Burrows, CFO: Arcutis Biotherapeutics ARQT Sell · Filed 23/03/02

Trade details

Type
Insider sale
Amount
$22,401.12
Shares · price
1,416 sh · $15.82 a share
Held after
38,424 sh
Trade date
23/03/02
Filed
23/03/02
Days to filing
0 days

Sold 3.6% of holdings

Share of holding sold
3.6%

Arcutis Biotherapeutics trades, last 26 weeks

What else happened in Arcutis Biotherapeutics around then

Filed or reported within 30 days of the trade day · 23/01/31~23/04/01

Scott L. Burrows's recent trades

  • Scott L. Burrows

    Planned saleSpyre Therapeutics

    $1.6M

    Filed 09/30

  • Scott L. Burrows

    Planned sale10b5-1 planSpyre Therapeutics

    $2.9M

    Filed 08/03

  • Scott L. Burrows

    SellSpyre Therapeutics

    $871.4K

    Filed 06/26

  • Scott L. Burrows

    SellSpyre Therapeutics

    $435.6K

    Filed 06/26

  • Scott L. Burrows

    Planned saleSpyre Therapeutics

    $1.3M

    Filed 06/25

Scott L. Burrows, CFO — sold $22.4K of Arcutis Biotherapeutics ARQT · 3.6% of holdings | Whalegun